Inhibrx, Inc. (INBX) Misses Q4 EPS by 48c

Inhibrx, Inc. (NASDAQ: INBX) reported Q4 EPS of ($2.11), $0.48 worse than the analyst estimate of ($1.63).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• DelphX launches private placement targeting up to C$50,000
• Largo restructures $82.2M in debt, extending maturity to 2030